INTESTINAL AND COLONIC CYTOCHROME P450 GENE EXPRESSION

肠道和结肠细胞色素 P450 基因表达

基本信息

  • 批准号:
    3463806
  • 负责人:
  • 金额:
    $ 10.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1989
  • 资助国家:
    美国
  • 起止时间:
    1989-04-01 至 1994-03-31
  • 项目状态:
    已结题

项目摘要

The epithelial cells lining the small intestine and colon are exposed to many ingested xenobiotics including drugs and environmental carcinogens. Cytochrome P450 isoenzymes, which are encoded by a large superfamily of related genes play an important role in the metabolism of xenobiotics and in the activation of- carcinogens. Preliminary data has indicated that phenobarbital- inducible P450 genes are regulated differently in small intestine and liver and that there is a complex pattern of regulation along the length of the small intestine and within the crypt-villus axis This proposal is based on the hypothesis that expression of genes in the P450 forms expressed in lever, small intestine and colon may determine the response of the individual tissues to toxins or susceptibility to carcinogens. This proposal will address several questions concerning the expression of P450 genes including 1) How are the patterns of expression and inducibility of these genes different in liver, intestine and colon?, 2) Are different members of these highly homologous gene families express in these three tissues?, 3) What are the molecular mechanisms by which the expression of these genes are induced by chemical compounds? and 4) What are the physiologic factors which regulate the expression of P450 genes along the length of small intestine and colon? The major P450 isoenzymes in rat which are inducible by various xenobiotics will be studied in intestinalesinal and colonic mucosa by measuring specific P450 mRNA with cDNA and oligonucleotide probes and P450 apoproteins using immunoblots. The distribution of P450 mRNA within the intestinal cryptvillus axis will be studied using in situ hybridization. P450 from which are expressed in small intestine and colon will be definitively identified using complementary DNA cloning. The mechanism for the induction of P450 expression by chemical inducers will be evaluated by measuring the rate of transcription of the genes and the half-life of mRNA in enterocytes. Finally, physiologic factors such as bile and gastrointestinal hormones, which may be responsible for maintaining expression of P450 genes in the small intestine and colon will be evaluated. These studies have potential importance in several areas. First, differential expression and inducibility of P450 genes in small intestine and colon may have ramifications regarding the response of these tissues to chemical carcinogens this may contribute to the marked difference in the susceptibility of these tissues to the development of cancer. Second differences in the expression of these genes in liver and intestine may provide further insight into the molecular mechanisms which regulate tissue-specific gene expression. And finally, the expression of P450 genes expression along the length of the intestine and as enterocytes mature along the crypt-villus axis.
排列在小肠和结肠内的上皮细胞是 接触到许多摄入的外来物质,包括药物和 环境致癌物质。细胞色素P450同工酶,它们是 由一个相关基因的大超家族编码,发挥着重要的作用 在外源生物的新陈代谢和激活- 致癌物质。初步数据表明,苯巴比妥- 可诱导的P450基因在小肠中的不同调控 和肝脏之间存在着一种复杂的调节模式 小肠和隐窝绒毛轴内的长度 这一建议是基于这样一个假设,即基因的表达 在杠杆、小肠和结肠表达的P450形式中, 确定单个组织对毒素或 对致癌物的易感性。这项提案将解决几个问题 关于P450基因表达的问题,包括1)如何表达 这些基因的表达模式和可诱导性 肝、肠、结肠不同?2)是不同的成员 在这些高度同源的基因家族中表达在这三个 组织?,3)分子机制是什么? 这些基因的表达是由化合物诱导的吗?和 4)调节表达的生理因素是什么? P450基因在小肠和结肠长度上的分布情况? 大鼠体内主要的P450同工酶可被不同种类的药物诱导 将在肠道和结肠粘膜中研究外源物质 用c DNA和寡核苷酸检测特异性P450 m RNA 用免疫印迹法检测探针和P450载脂蛋白。分布情况 将对肠道隐绒毛轴内的P450 mRNA进行研究 采用原位杂交技术。P450,其表达形式为 小肠和结肠将被确定为使用 互补DNA克隆。P450的诱导机制 化学诱导剂的表达将通过测量 基因的转录速率和mRNA的半衰期 肠道细胞。最后,胆汁和胆汁等生理因素 胃肠激素,这可能是维持 P450基因在小肠和结肠中的表达将是 已评估。 这些研究在几个领域具有潜在的重要性。第一, 小鼠P450基因的差异表达及诱导性 肠道和结肠可能会对反应产生影响 这些组织中的化学致癌物,这可能有助于 这些组织的敏感性有显著差异 癌症的发展。表达的第二个差异 肝脏和肠道中的这些基因可能提供进一步的洞察 调控组织特异性基因的分子机制 表情。最后,P450基因的表达和表达 沿着肠道的长度,随着肠道细胞的成熟 地穴-绒毛轴。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER G TRABER其他文献

PETER G TRABER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER G TRABER', 18)}}的其他基金

CORE--MORPHOLOGY FACILITY
核心——形态学设施
  • 批准号:
    6501890
  • 财政年份:
    2001
  • 资助金额:
    $ 10.54万
  • 项目类别:
CORE--MORPHOLOGY FACILITY
核心——形态学设施
  • 批准号:
    6219021
  • 财政年份:
    1999
  • 资助金额:
    $ 10.54万
  • 项目类别:
CORE--MORPHOLOGY FACILITY
核心——形态学设施
  • 批准号:
    6105735
  • 财政年份:
    1998
  • 资助金额:
    $ 10.54万
  • 项目类别:
CORE--MORPHOLOGY FACILITY
核心——形态学设施
  • 批准号:
    6270815
  • 财政年份:
    1998
  • 资助金额:
    $ 10.54万
  • 项目类别:
GI TRACT CONF--DEVELOPMENT, DIFFERENTIATION, ADAPTATION
胃肠道配置——发育、分化、适应
  • 批准号:
    2372406
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:
CENTER FOR DIGESTIVE AND LIVER DISEASES
消化和肝脏疾病中心
  • 批准号:
    2017053
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:
CORE--MORPHOLOGY FACILITY
核心——形态学设施
  • 批准号:
    6239271
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:
CENTER FOR DIGESTIVE AND LIVER DISEASES
消化和肝脏疾病中心
  • 批准号:
    2905781
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:
CENTER FOR DIGESTIVE AND LIVER DISEASES
消化和肝脏疾病中心
  • 批准号:
    2876575
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:
CENTER FOR DIGESTIVE AND LIVER DISEASES
消化和肝脏疾病中心
  • 批准号:
    2734209
  • 财政年份:
    1997
  • 资助金额:
    $ 10.54万
  • 项目类别:

相似海外基金

I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
  • 批准号:
    2425300
  • 财政年份:
    2024
  • 资助金额:
    $ 10.54万
  • 项目类别:
    Standard Grant
The investigation of chronic alcohol consumption enhanced aging colon in elder mice and the mechanism of suppressed on aging colon tissues by sesame lignans continuous intake
长期饮酒促进老年小鼠结肠衰老的研究及持续摄入芝麻木脂素抑制结肠组织衰老的机制
  • 批准号:
    23K10904
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Self-Propelled Colonoscopy Robot using a Soft Gear Mechanism, which Fits Flexibly inside the Colon
使用软齿轮机构的自行式结肠镜检查机器人,可灵活地安装在结肠内
  • 批准号:
    23K17236
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of Serrated Colon Tumor Suppression
锯齿状结肠肿瘤抑制机制
  • 批准号:
    10681608
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention
针对癌症干细胞样细胞和炎症进行结肠癌化学预防
  • 批准号:
    10650910
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
  • 批准号:
    10737017
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
Epigenetic regulation of lineage specification in colon epithelial cells
结肠上皮细胞谱系规范的表观遗传调控
  • 批准号:
    10676682
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
Generation of chimeric antigen receptor T cells using antibodies derived from colon cancer tumor-associated B cells.
使用源自结肠癌肿瘤相关 B 细胞的抗体生成嵌合抗原受体 T 细胞。
  • 批准号:
    23K15473
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Defining and modeling the cellular interactions for rhythmic colon motility
节律性结肠运动的细胞相互作用的定义和建模
  • 批准号:
    10711530
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
Enteric Glia is New Biological Target to Block Drug Resistance in Colon Cancer
肠胶质细胞是阻断结肠癌耐药性的新生物靶点
  • 批准号:
    10659846
  • 财政年份:
    2023
  • 资助金额:
    $ 10.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了